Deltec Asset Management’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-5,000
Closed -$229K – 274
2021
Q4
$229K Hold
5,000
– – 0.04% 219
2021
Q3
$237K Hold
5,000
– – 0.04% 246
2021
Q2
$232K Hold
5,000
– – 0.03% 264
2021
Q1
$219K Hold
5,000
– – 0.03% 265
2020
Q4
$205K Buy
+5,000
New +$195K 0.03% 202
2019
Q4
– Sell
-48,000
Closed -$1.55M – 181
2019
Q3
$1.55M Hold
48,000
– – 0.39% 49
2019
Q2
$1.65M Sell
48,000
-2,000
-4% -$67.4K 0.36% 56
2019
Q1
$1.68M Buy
+50,000
New +$1.57M 0.37% 61

Other funds holding FFTY

Deltec Asset Management's FFTY Position: Q1 2022 in Review

Deltec Asset Management sold out of CapForce IBD 50 ETF (FFTY) in Q1 2022, closing a stake of 5,000 shares — an estimated $229K sold.

Deltec Asset Management first reported a position in FFTY in Q1 2019 and held it in 8 quarters. The position peaked at $1.68M in Q1 2019. 70 funds tracked by Wall St. Rank hold FFTY as of Q1 2022.

  • Deltec Asset Management reported no remaining CapForce IBD 50 ETF position as of Q1 2022 after selling out during the quarter.
  • Deltec Asset Management sold 5,000 CapForce IBD 50 ETF shares in Q1 2022, an estimated $229K.
  • Deltec Asset Management first reported a position in CapForce IBD 50 ETF in Q1 2019 and held it in 8 quarters.
  • Deltec Asset Management's CapForce IBD 50 ETF position peaked at $1.68M in Q1 2019.
  • 70 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2022.

Based on Deltec Asset Management's 13F filing for Q1 2022, filed 11 Apr 2022.